PMN
ProMIS Neurosciences Inc.
9.40$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +221.0% | -94.3% | +23,972.7% | -97.5% | -98.3% | – | – | +133.3% | -105.8% | – | -56.4% | +14,364.5% | – | – | – | – | – | – | – | -19.3% | +24.1% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +41,369.9% | +6.4% | -80.1% | +734.8% | -49.8% | -99.7% | – | – | – | -46.6% | -41.1% | -99.8% | +51,838.0% | +12.0% | -7.7% | +17.2% | -75.6% | +7.4% | -95.5% | +8,113.4% | +253.0% | -34.0% | -99.9% | -7.9% | -33.4% | -25.7% | -20.4% | -72.1% | – | – | +12,241.2% | +55.9% | +24.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -1,627,138.7% | – | – | -56.4% | -10,441,989.3% | – | – | – | – | – | – | – | – | -57,576.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +88.1% | -21.2% | +56.8% | +14.2% | -51.0% | +11.0% | +115.4% | +24.2% | +136.3% | -61.2% | -21.4% | +1.0% | -17.5% | +12.0% | -7.7% | +17.2% | -75.6% | +7.4% | +209.9% | -5.8% | +275.8% | -21.5% | +74.9% | +50.7% | +36.9% | -44.7% | -71.9% | -14.3% | +94.8% | -4.6% | -23.4% | +57.7% | +68.7% | +26.4% | +60.1% | +12.0% | -4.4% | -25.6% | +36.6% | – | |
| – | +27.6% | +32.7% | +25.2% | -46.5% | +12.4% | +87.2% | -21.8% | +55.5% | -96.1% | +1,510.9% | +61.2% | -45.9% | +30.2% | +35.7% | -3.5% | -32.2% | -16.8% | +3.1% | -0.6% | +190.7% | +65.5% | +21.4% | -17.2% | -3.4% | +41.2% | -31.2% | +27.0% | -45.2% | +19.9% | -5.9% | -29.9% | +72.0% | -10.3% | +19.0% | -28.1% | +36.1% | -28.1% | +19.2% | +64.0% | – | |
| – | +39.8% | +22.9% | +22.1% | -49.0% | +29.2% | +69.5% | +96.1% | +33.9% | -543.5% | – | -24.0% | -11.9% | -11.2% | -288.1% | – | – | – | -95.8% | +205.5% | +54.8% | +147.1% | -3.8% | +27.3% | +32.5% | +38.0% | -41.3% | -42.9% | -34.5% | +53.9% | -5.1% | -26.2% | +63.4% | +35.4% | +24.3% | +36.5% | +15.4% | -8.3% | -19.7% | +41.9% | – | |
| – | – | – | – | – | – | – | – | – | – | -163.1% | – | – | – | – | -6.3% | -5.2% | -780.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.1% | +11.6% | +4.4% | -2.8% | -95.8% | – | – | – | – | – | – | -56.0% | – | – | – | – | – | – | +6,087.8% | +5.4% | +4.9% | +24.9% | -6.3% | -43.8% | -90.6% | +23.1% | +479.7% | +15.7% | +1.8% | 0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -102.6% | – | – | – | – | – | – | – | |
| – | -12.2% | +11.6% | +4.4% | -2.8% | -104.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | -115.7% | – | – | – | – | – | – | – | – | +135.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -102.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -164.7% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.